journal article·2026-05-26

Zwitterionic Lipid Nanotherapeutics from Mulberry for Oral Treatment of Diabetic Colitis

Yingui Cao, Haiting Xu, Cheng Xu, Menghang Zu, Jianfeng Sun, Dapeng Xiong, Jun Ye, Kai Han, Qiang Gao, Xiaoxiao Shi, Liqi Li, Bozhao Li, Mohammad-Ali Shahbazi, Adam P. Cribbs, Jin Chai, Rui L. Reis, Subhas C. Kundu, Yuling Liu, Guangjun Nie, Bo Xiao

ACS Nano· Volume 20· Issue 20
Publisher page

Abstract

Diabetic colitis is a severe gastrointestinal complication of type 2 diabetes, which presents the key pathophysiological hallmarks of hyperglycemia, intestinal barrier disruption, immune dysregulation, and microbial metabolic imbalance, posing significant therapeutic challenges in clinical practice. Here, we leveraged artificial intelligence to identify the therapeutic potential of 1-deoxynojirimycin (DNJ) for addressing diabetic colitis. To improve its bioavailability and efficacy, we developed a mulberry-derived nanotherapeutic with surface functionalization of zwitterionic polymer (PpC) for DNJ encapsulation. Following oral administration, the resultant nanotherapeutics, PpC@DNJ-LNPs, efficiently traversed the gastrointestinal tract, enabling controlled DNJ release while inhibiting the α-glucosidase activity to regulate glucose homeostasis. Concurrently, they orchestrated colonic mucosa-microbiome interaction, promoting intestinal immune balance and microbiota remodeling. These synergistic effects collectively confer hypoglycemic, anti-inflammatory, antioxidant, and epithelial barrier-restoring effects, ultimately reshaping the glucose level and intestinal microecology. Our study demonstrates the translational potential of PpC@DNJ-LNPs as a safe and effective oral therapeutic platform for diabetic colitis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Pharmacological Effects of Medicinal Plants · Curcumin's Biomedical Applications · Medicinal Plants and Neuroprotection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Resource Insects, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Beibei, Chongqing 400715, China

Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine

University of Electronic Science and Technology of China

Botnar Research Centre, Nuffield Department of Orthopedics Rheumatology and Musculoskeletal Sciences

University of Oxford, Headington

Department of Computational Biology

Cornell University

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation

Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery

China Pharmaceutical University

Department of General Surgery, Xinqiao Hospital, Third Military Medical University (Army Medical University), Shapingba, Chongqing 400037, China

National Center for Nanoscience and Technology

Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen 9713 AV, Netherlands

Department of Gastroenterology, Institute of Digestive Diseases of PLA, Cholestatic Liver Diseases Center and Center for Metabolic-Associated Fatty Liver Disease, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Shapingba, Chongqing 400038, China

3Bs Research Group I3Bs–Research Institute on Biomaterials, Biodegradables, and Biomimetics, University of Minho Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães 4805-017, Portugal

Funding

China Association for Science and Technology · China Postdoctoral Science Foundation · Natural Science Foundation of Sichuan Province · Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission · National Natural Science Foundation of China · Sichuan Academy of Medical Sciences and Sichuan Provincial People?s Hospital

References (46)

Show source-provided references
1. 10.1038/s41575-022-00581-210.1038/s41575-022-00581-2 ↗
2. 10.1038/s41577-019-0198-410.1038/s41577-019-0198-4 ↗
3. 10.26502/aimr.017810.26502/aimr.0178 ↗
4. 10.1016/j.clnesp.2024.03.02210.1016/j.clnesp.2024.03.022 ↗
5. 10.1038/s41551-023-01090-610.1038/s41551-023-01090-6 ↗
6. 10.1038/s41573-023-00670-010.1038/s41573-023-00670-0 ↗
7. 10.1016/j.addr.2021.11388710.1016/j.addr.2021.113887 ↗
8. 10.1016/j.ajps.2021.05.00610.1016/j.ajps.2021.05.006 ↗
9. 10.1021/acsnano.3c1143610.1021/acsnano.3c11436 ↗
10. 10.1016/j.apsb.2021.08.01610.1016/j.apsb.2021.08.016 ↗
11. 10.1038/s41591-024-03434-410.1038/s41591-024-03434-4 ↗
12. 10.1080/10408398.2021.198966010.1080/10408398.2021.1989660 ↗
13. 10.1038/ng.48310.1038/ng.483 ↗
14. 10.1038/s41374-017-0005-410.1038/s41374-017-0005-4 ↗
15. 10.1053/j.gastro.2021.12.28810.1053/j.gastro.2021.12.288 ↗
16. 10.1530/JME-17-015210.1530/JME-17-0152 ↗
17. 10.1126/science.add578710.1126/science.add5787 ↗
18. 10.1016/j.eclinm.2021.10097910.1016/j.eclinm.2021.100979 ↗
19. 10.1016/j.ejmech.2023.11550010.1016/j.ejmech.2023.115500 ↗
20. 10.1038/s41422-022-00645-710.1038/s41422-022-00645-7 ↗
21. 10.1038/s42255-021-00458-910.1038/s42255-021-00458-9 ↗
22. 10.34133/research.018810.34133/research.0188 ↗
23. 10.1016/j.addr.2021.11402110.1016/j.addr.2021.114021 ↗
24. 10.1016/j.addr.2008.11.00210.1016/j.addr.2008.11.002 ↗
25. 10.1186/s12951-022-01539-x10.1186/s12951-022-01539-x ↗
26. 10.1016/j.addr.2017.10.00110.1016/j.addr.2017.10.001 ↗
27. 10.1016/j.addr.2021.11408310.1016/j.addr.2021.114083 ↗
28. 10.1080/19490976.2020.178889910.1080/19490976.2020.1788899 ↗
29. 10.1073/pnas.200004711710.1073/pnas.2000047117 ↗
30. 10.3389/fimmu.2020.0127310.3389/fimmu.2020.01273 ↗
31. 10.7150/thno.4768310.7150/thno.47683 ↗
32. 10.1016/j.xcrm.2024.10173810.1016/j.xcrm.2024.101738 ↗
33. 10.1016/j.cytogfr.2023.07.00110.1016/j.cytogfr.2023.07.001 ↗
34. 10.1016/j.biopha.2020.11070810.1016/j.biopha.2020.110708 ↗
35. 10.1038/s41574-018-0007-310.1038/s41574-018-0007-3 ↗
36. 10.1038/s41574-022-00683-610.1038/s41574-022-00683-6 ↗
37. 10.3748/wjg.v20.i13.350710.3748/wjg.v20.i13.3507 ↗
38. 10.2337/dc20-210910.2337/dc20-2109 ↗
39. 10.1038/s41467-017-01261-510.1038/s41467-017-01261-5 ↗
40. 10.1038/ng.395410.1038/ng.3954 ↗
41. 10.1038/s41588-020-0653-y10.1038/s41588-020-0653-y ↗
42. 10.1038/s41467-017-02317-210.1038/s41467-017-02317-2 ↗
43. 10.1038/s41588-020-0631-410.1038/s41588-020-0631-4 ↗
44. 10.1007/s10654-017-0255-x10.1007/s10654-017-0255-x ↗
45. 10.1002/gepi.2175810.1002/gepi.21758 ↗
46. 10.1093/ije/dyx10210.1093/ije/dyx102 ↗